Soleus Capital Management, L.P. Exact Sciences Corp Transaction History

Soleus Capital Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $3.79 Million - $6.8 Million	91,611 New	91,611 $3.87 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $2.16 Million - $3.24 Million	32,696 Added 47.04%	102,196 $6.97 Million
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $24.3 Million - $36.8 Million	-387,000 Reduced 84.78%	69,500 $6.53 Million
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $7.98 Million - $12 Million	169,200 Added 58.89%	456,500 $31 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $4.32 Million - $7.57 Million	142,500 Added 98.41%	287,300 $14.2 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $824,826 - $1.27 Million	25,800 Added 21.68%	144,800 $4.71 Million
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $4.24 Million - $9.07 Million	119,000 New	119,000 $4.69 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.